Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient asymmetric synthesis of chiral indolinone spiro compounds using cinchona alkaloid catalysts for high-purity pharmaceutical intermediates.
Patent CN102153571B details a novel chiral zinc-nitrogen complex enabling efficient asymmetric cyanosilylation. Discover cost-effective supply chain solutions.
Patent CN101781197B reveals a high-yield route for chiral binaphthyl dicarboxylic acid. Achieve >99% optical purity without chromatography for cost-effective supply.
Discover the advanced asymmetric hydrogenation process for levo-nicotine. Achieve 99.7% optical purity with scalable, cost-effective pharmaceutical intermediate manufacturing.
Patent CN105669766B reveals high-efficiency spiro-rhodium complexes for asymmetric synthesis. Enhance supply chain reliability and reduce manufacturing costs with scalable solutions.
Novel titanium-catalyzed process for high-purity statin intermediates. Delivers >99% ee and superior yields for reliable API manufacturing supply chains.
Patent CN115466288B reveals a room-temperature method for chiral diphosphine selenium ligands, offering high yield and simplified supply chains for asymmetric catalysis manufacturing.
Patent CN110305122B reveals advanced C4-functionalized Pybox ligands offering superior enantioselectivity and streamlined synthesis for pharmaceutical intermediate manufacturing.
Novel immobilized transition metal complexes enable efficient asymmetric hydrogenation of ketoesters, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel CDOP-based synthesis route offers cost-effective chiral ligands. Enhances supply chain stability and reduces manufacturing complexity for asymmetric synthesis applications.
Patent CN1233648C reveals a novel salen catalyst enabling reusable, high-optical-purity epoxide production with significant cost and supply chain advantages.
Patent CN104003991A details a novel asymmetric synthesis for Balasubramide derivatives. Achieve high enantioselectivity and scalable production for neuroprotective drug development.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN106365949A reveals a breakthrough in chiral spiroindane synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel organocatalytic route for chiral octahydroacridines using silane-modified proline. High yield, mild conditions. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN111606868B discloses a high-yield synthesis for bidentate oxazoline ligands. Discover cost-effective manufacturing and supply chain advantages for chiral intermediates.
Novel dehydroabietylamine-based catalyst enables high-yield Morita-Baylis-Hillman reactions with up to 94% yield and 89% ee, offering cost-effective asymmetric synthesis solutions.
Novel patent CN103402973A details a shikimic acid-free route for Tamiflu precursors, offering supply chain stability and cost efficiency for pharmaceutical manufacturers.
Patent CN117659018A details novel chiral ligands enabling high-purity pharmaceutical intermediate manufacturing with significant cost reduction and supply chain reliability.
Patent CN111574487A details asymmetric hydrogenation for chiral dihydroisoflavones. Offers high enantioselectivity and scalable routes for pharmaceutical intermediates.